Skip to main content

Table 3 Summary Statistics at Patient Level, 2005 - 2007

From: Benefits of global partnerships to facilitate access to medicines in developing countries: a multi-country analysis of patients and patient outcomes in GIPAP

Participants (Total)

 

13,568

 

Average Age (years)

 

38.69

 

Average Time Gap between Diagnosis and Approval (months)

 

4.61

 

Age Group

No. of patients

No. of observations

0-20

1,332

9.82%

6474

9.71%

21-30

2,786

20.53%

13,970

20.95%

31-40

3,646

26.87%

18,273

27.40%

41-50

2,914

21.48%

14,191

21.28%

51-60

1,895

13.97%

9,185

13.77%

61-70

758

5.59%

3594

5.39%

71+

237

1.75%

994

1.49%

Total

13,568

100.00%

66,681

100.00%

Gender

 

No. of patients

 

No. of observations

 

Male

8,453

62.30%

41,873

62.80%

Female

5,115

37.70%

24,808

37.20%

Total

13,568

100.00%

66,681

100.00%

Original Phase

 

No. of patients

No. of observations

Chronic

11,414

84.14%

57,728

86.57%

Accelerated

1,228

9.05%

5,958

8.94%

Blast Crisis

923

6.80%

2,995

4.49%

Total

13565

100.00%

66,681

100.00%

Current Phase

 

No. of patients 1

No. of observations

Chronic

N/A

54,192

81.27%

Accelerated

  

4,587

6.88%

Blast Crisis

  

2,794

4.19%

Remission

  

5,108

7.66%

Total

  

66,681

100.00%

Status

 

No. of patients 1

No. of observations

Closed

N/A

3,734

5.60%

Active

  

62,947

94.40%

Total

  

66,681

100.00%

  1. Note: 1 Although we do have data at patient level, we cannot report summary statistics here, as this changes per patient over time. Thus, statistics are only reported per observation, not per patient.
  2. Source: Authors' compilations from GIPAP database.